相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。The AMPK stress response pathway mediates anoikis resistance through inhibition of mTOR and suppression of protein synthesis
T. L. Ng et al.
CELL DEATH AND DIFFERENTIATION (2012)
Polymorphic variants in TSC1 and TSC2 and their association with breast cancer phenotypes
Madhura S. Mehta et al.
BREAST CANCER RESEARCH AND TREATMENT (2011)
Variation in genes coding for AMP-activated protein kinase (AMPK) and breast cancer risk in the European Prospective Investigation on Cancer (EPIC)
Daniele Campa et al.
BREAST CANCER RESEARCH AND TREATMENT (2011)
Clinical potential of the mTOR targets S6K1 and S6K2 in breast cancer
Gizeh Perez-Tenorio et al.
BREAST CANCER RESEARCH AND TREATMENT (2011)
Evaluation of variation in the phosphoinositide-3-kinase catalytic subunit alpha oncogene and breast cancer risk
K. N. Stevens et al.
BRITISH JOURNAL OF CANCER (2011)
Healthy Lifestyle on the Risk of Breast Cancer
Luisa Maria Sanchez-Zamorano et al.
CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION (2011)
Targeting the Phosphoinositide-3 (PI3) Kinase Pathway in Breast Cancer
Jose Baselga
ONCOLOGIST (2011)
Serum insulin-like growth factor (IGF)-1 and IGF binding protein-3 in relation to breast cancer among Hispanic and white, non-Hispanic women in the US Southwest
Dana E. Rollison et al.
BREAST CANCER RESEARCH AND TREATMENT (2010)
Moderate physical activity and breast cancer risk: the effect of menopausal status
Angelica Angeles-Llerenas et al.
CANCER CAUSES & CONTROL (2010)
European Ancestry Is Positively Associated with Breast Cancer Risk in Mexican Women
Laura Fejerman et al.
CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION (2010)
Biomarkers and Patient Selection for PI3K/Akt/mTOR Targeted Therapies: Current Status and Future Directions
John M. S. Bartlett
CLINICAL BREAST CANCER (2010)
Deciphering the Role of PI3K/Akt/mTOR Pathway in Breast Cancer Biology and Pathogenesis
Priscilla F. McAuliffe et al.
CLINICAL BREAST CANCER (2010)
Immunohistochemical study of PTEN and phosphorylated mTOR proteins in familial and sporadic invasive breast carcinomas
Panagiotis Bakarakos et al.
HISTOPATHOLOGY (2010)
Osteopontin selectively regulates p70S6K/mTOR phosphorylation leading to NF-κB dependent AP-1-mediated ICAM-1 expression in breast cancer cells
Mansoor Ahmed et al.
MOLECULAR CANCER (2010)
Convergence of Hormones, Inflammation, and Energy-Related Factors: A Novel Pathway of Cancer Etiology
Martha L. Slattery et al.
CANCER PREVENTION RESEARCH (2009)
Common corruption of the mTOR signaling network in human tumors
S Menon et al.
ONCOGENE (2009)
Comparison of Akt/mTOR signaling in primary breast tumors and matched distant metastases
Argun Akcakanat et al.
CANCER (2008)
Genetic Ancestry and Risk of Breast Cancer among US Latinas
Laura Fejerman et al.
CANCER RESEARCH (2008)
Sun exposure, vitamin D receptor gene polymorphisms, and breast cancer risk in a multiethnic population
Esther M. John et al.
AMERICAN JOURNAL OF EPIDEMIOLOGY (2007)
Decreased levels of hypoxic cells in gefitinib treated ER+ HER-2 overexpressing MCF-7 breast cancer tumors are associated with hyperactivation of the mTOR pathway:: Therapeutic implications for combination therapy with rapamycin
Wieslawa H. Dragowska et al.
BREAST CANCER RESEARCH AND TREATMENT (2007)
So many correlated tests, so little time!: Rapid adjustment of P values for multiple correlated tests
Karen N. Conneely et al.
AMERICAN JOURNAL OF HUMAN GENETICS (2007)
IKKβ suppression of TSC1 links inflammation and tumor angiogenesis via the mTOR pathway
Dung-Fang Lee et al.
CELL (2007)
Genetic variation in IGF1, IGFBP3, IRS1, IRS2 and risk of breast cancer in women living in Southwestern United States
M. L. Slattery et al.
BREAST CANCER RESEARCH AND TREATMENT (2007)
Akt-induced endocrine therapy resistance is reversed by inhibition of mTOR signaling
M. Beeram et al.
ANNALS OF ONCOLOGY (2007)
Body size, weight change, fat distribution and breast cancer risk in Hispanic and non-Hispanic white women
Martha L. Slattery et al.
BREAST CANCER RESEARCH AND TREATMENT (2007)
Genetic admixture among Hispanics and candidate gene polymorphisms: Potential for confounding in a breast cancer study?
Carol Sweeney et al.
CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION (2007)
IL6, aspirin, nonsteroidal anti-inflammatory drugs, and breast cancer risk in women living in the southwestern United States
Martha L. Slattery et al.
CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION (2007)
Rapamycin synergizes with the epidermal growth factor receptor inhibitor erlotinib in non-small-cell lung, pancreatic, colon, and breast tumors
Elizabeth Buck et al.
MOLECULAR CANCER THERAPEUTICS (2006)
Genetic ancestry and risk factors for breast cancer among Latinas in the San Francisco Bay Area
Elad Ziv et al.
CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION (2006)
Common genetic variation at PTEN and risk of sporadic breast and prostate cancer
CA Haiman et al.
CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION (2006)
Migration history, acculturation, and breast cancer risk in Hispanic women
EM John et al.
CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION (2005)
The AKT/IκB kinase pathway promotes angiogenic/metastatic gene expression in colorectal cancer by activating nuclear factor-κB and β-catenin
A Agarwal et al.
ONCOGENE (2005)
The tumor suppressor LKB1 kinase directly activates AMP-activated kinase and regulates apoptosis in response to energy stress
RJ Shaw et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2004)
LKB1 is a master kinase that activates 13 kinases of the AMPK subfamily, including MARK/PAR-1
JM Lizcano et al.
EMBO JOURNAL (2004)
The AMP-activated protein kinase cascade - a unifying system for energy control
D Carling
TRENDS IN BIOCHEMICAL SCIENCES (2004)
LKB1 is the upstream kinase in the AMP-activated protein kinase cascade
A Woods et al.
CURRENT BIOLOGY (2003)
Physiological role of AMP-activated protein kinase (AMPK): insights from knockout mouse models
B Viollet et al.
BIOCHEMICAL SOCIETY TRANSACTIONS (2003)
Polymorphic variants of NFKB1 and its inhibitory protein NFKBIA, and their involvement in sporadic breast cancer
JE Curran et al.
CANCER LETTERS (2002)
分享论文
